Dehradun (Uttarakhand) [India], April 14 (ANI): While the demand for hydroxychloroquine tablets keeps on rising worldwide, small pharmaceutical manufacturers in Haridwar have stopped producing the drug due to the sharp increase in the cost of raw materials, according to Anil Sharma, Presiden
Dehradun (Uttarakhand) [India], April 13 (ANI): Amid worldwide surge in demand of Hydroxychloroquine tablets for the treatment of COVID-19, the pharmaceutical companies based in Uttarakhand are facing crisis as there is a shortage of supply of raw materials.
New Delhi [India], April 12 (ANI): The Central government on Sunday approved the release of Hydroxychloroquine (HCQ) for 13 countries after keeping the buffer stock.
New Delhi [India], April 12 (ANI): AIIMS Director Dr Randeep Guleria on Sunday warned the general public against the use of hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, without proper approval from doctors, stating that it can be harmful leading
Shimla (Himachal Pradesh) [India], April 12 (ANI): As the demand for hydroxychloroquine surges worldwide during COVID-19 crisis, Himachal Pradesh is speeding up the production of the drug to ensure that both domestic and international requirements are met.
Washington DC [US], April 12 (ANI): A consignment of hydroxychloroquine from India arrived at the Newark airport on Saturday (local time), according to India's Ambassador to the US, Taranjit Singh Sandhu.
Mumbai (Maharashtra) [India], April 11 (ANI): The Joint Managing Director of Ipca Laboratories Ajit Kumar Jain on Saturday said that hydroxychloroquine is not approved as an anti-malarial drug in India.
Thimphu [Bhutan], April 11 (ANI): Bhutan on Saturday thanked India for facilitating the evacuation of Bhutanese stranded in India due to coronavirus lockdown.
New Delhi [India], April 11 (ANI): The Indian Council of Medical Research (ICMR) on Saturday said that hydroxychloroquine or HCQ should be used as prophylaxis to prevent the coronavirus and not as a treatment for COVID-19.
Islamabad [Pakistan], April 11 (ANI): Pakistan has re-imposed the ban on export of all anti malaria drugs including hydroxychloroquine or HCQ, touted as a potential treatment for the coronavirus, four days after it lifted the hold on them.
Ahmedabad (Gujarat) [India], April 11 (ANI): With the surge in demand for hydroxychloroquine, an anti-malarial drug deemed to be useful in dealing with COVID-19, the pharmaceutical industry has produced 20 crore HCQ tablets this month, said Pankaj Patel, CEO of Zydus Cadila in Ahmedabad, on
Baddi (Himachal Pradesh) [India], April 11 (ANI): With the demand for hydroxychloroquine, an anti-malarial drug, rising substantially in the wake of coronavirus pandemic, efforts are being made to speed up its production in Himachal Pradesh.